The views expressed in these articles and commentaries are those of the author at the time created.  They do not necessarily reflect the views of FPA or the distributor.  These views are subject to change at any time based on market and other conditions, and FPA and/or the Distributor disclaims any responsibility to update such views.  No forecasts can be guaranteed. These views may not be relied upon as investment advice or as indication of trading intent on behalf of any FPA portfolio or the distributor and should not be construed as an offer to sell or a solicitation of an offer to buy securities or any product mentioned in this article. This information and data has been prepared from sources believed reliable.  However, the accuracy and completeness of the information cannot be guaranteed and is not a complete summary or statement of all available data.  FPA has received certain nominations or awards by third-parties as reflected herein.  Investors should review the criteria for each nomination or award as reflected on the third-party’s webpage.

 

February 1, 2019

Barron's Q&A with FPA Crescent (FPACX) Portfolio Manager, Steven Romick

This article has been reprinted from Barrons. Please note that any references in this article to specific securities are being provided as a means of illustrating our investment thesis and should not be construed as a recommendation by the strategy, the portfolio managers, FPA or the distributor to purchase or sell such securities, and any information provided is not a sufficient basis upon which to make an investment decision. It should not be assumed that future investments will be profitable or will equal the performance of the security examples discussed. Past performance is no guarantee, nor is it indicative, of future results. Certain information in this article reflects the opinions of the portfolio managers of the Contrarian Value investment team as of the date provided and are subject to change.
For further details, please click here.